Clinical Trials Browser

Phase 3 × Thyroid Neoplasms × Sorafenib × Clear all

NCT00984282 2018-09-13

Nexavar® Versus Placebo in Locally Advanced/Metastatic RAI-Refractory Differentiated Thyroid Cancer

Phase 3 Completed

417 enrolled 22 charts

Thyroid Neoplasms